港股早評:恒指微幅高開0.01%,科技股、汽車股普升,恒大汽車復牌開跌超22%
中國重磅會議即將召開,上週五納指刷新高,中概指數強勢。港股小幅高開,恒指升0.01%,國指升0.09%,恒生科技指數升0.57%。盤面上,大型科技股普遍上升,小米升1.35%,快手、美團、阿里巴巴、百度飄紅;中德汽車產業共同呼籲合作,深化投資貿易合作,汽車股上升明顯,新能源車升幅居前,小鵬汽車升近5%,蔚來汽車、零跑汽車升超3%;有色金屬股、電力股、餐飲股、體育用品股齊升,金力永磁績後高開5%。另一方面,內險股、生物醫藥股普跌,陽光保險跌超5%,潛在股份轉讓討論已終止,恒大汽車復牌大幅低開超22%。(格隆匯)
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.